fecal transplant

A first-of-its-kind clinical trial has found fecal transplants may be helpful reducing drinking behaviors in those suffering severe alcohol use disorder. The study points to a compelling relationship between the gut microbiome and addiction disorders.

Scientists exploring new treatments for obesity have found that implanting virus particles gleaned from the feces of lean mice into mice on a high-fat diet curtailed weight gain and progression of a precursor of type 2 diabetes.

A new study led by University of Queensland researchers is suggesting fecal transplants may help koalas in Australia adapt to new habitats.

A new safety alert, issued by the Food and Drug Administration (FDA), is recommending extra precautions for those medical and scientific professionals using fecal microbiota transplants (FMT) after revealing one person recently died due to a bacterial infection.

Two studies are shedding light on the links between the gut, the brain, and autism. The research reveals how gut problems can be triggered by the same gene mutations associated with autism, and a study shows how a fecal transplant from humans with autism can promote autism-like behaviors in mice.

Researchers are reporting mixed results from the first human trial investigating the effects of fecal transplantation in obese patients. Initial reports suggest the treatment failed to induce weight loss or changes in a key satiety hormone.

​​Scientiists continue to uncover new connections between the gut microbiome and human health. Another example of this are the emerging ties between gut health and autism, with an exciting new study demonstrating how fecal transplants can dramatically reduce its symptoms in the long term. ​

A new study, led by researchers from the University of Auckland, has described the phenomenon of "super donors," people who contribute stool samples for use in trials whose poop seems to be significantly more effective in leading to clinical improvements for fecal transplant subjects.

A new Australian trial has revealed significant success in fecal transplants treating ulcerative colitis, pioneering a new stool processing technique suggested to enhance the therapeutic effect of the treatment.

OpenBiome is paying donors for their doo-doo in an effort to gather more materials for fecal microbiota transplants (FMTs), a relatively new, but 90 percent effective, treatment for the debilitating Clostridium difficile infection (CDI).